RAPP Financials
Rapport Therapeutics, Inc. Common Stock - Financial statements & key metrics
Stock Price
$48.56
Market Cap
$532.87M
P/E Ratio
-12.8
EPS
$-2.27
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-78.31M
EPS (Diluted)
$-3.78
Balance Sheet Highlights
Total Assets
$314.93M
Total Liabilities
$9.51M
Shareholders Equity
-
Cash & Equivalents
$56.80M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-64.83M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-23.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is RAPP revenue?
View RAPP's income statement for detailed revenue data.
Is RAPP profitable?
RAPP reported a loss of $78.31M in the most recent quarter.
What is RAPP market cap?
RAPP has a market capitalization of $532.87M, making it a small-cap stock.
Does RAPP have debt?
View RAPP's balance sheet for debt information.
What is RAPP cash flow?
Cash flow data is available in the full financial statements.